Jiangsu Yifeng Medical Technology Co., Ltd. Is a company founded by seasoned professionals in the Chinese biotechnology industry, with expertise in research and development, management, and marketing. With a registered capital of 10 million RMB, the company is located in the West Taihu Lake Medical Device Industrial Park in Changzhou. Yifeng Medical focuses on the field of in vitro diagnostics within the medical equipment sector, specializing in the research, production, and sales of rapid diagnostic reagents for point-of-care testing.

The company boasts a 900-square-meter Class 100, 000 clean production workshop and a 200-square-meter laboratory, equipped with a complete set of production lines for rapid diagnostic reagents and advanced testing equipment. Additionally, research laboratories spanning 300 square meters each are established in Hangzhou and Jinan, staffed with a team of 10 experienced research and development professionals. Core technologies include small molecule antigen synthesis, immunochromatography technology, and the development and production of reagent kits.

The company has established a multi-project rapid testing technology platform with urine, saliva, feces, and whole blood as sample types. Its colloidal gold rapid diagnostic products cover five major categories: Pregnancy, chronic diseases, drugs of abuse, tumor markers, and myocardial markers.

Adhering to the quality policy of "Customer satisfaction as the aim, quality as the lifeblood of the enterprise, " the company operates with the mission of "making health testing accessible. " It explores markets, rigorously manages its operations, fosters innovation, and provides high-quality products and services to customers worldwide. It continues to expand its extensive and friendly cooperation with knowledgeable individuals and agents, jointly committed to the industrial development of in vitro diagnostic reagents.